SERPINA1 and hyperinsulinemic hypoglycemia, familial, 4: Gene therapy for AAT deficiency offers the potential for a onetime administration to provide therapeutic levels of AAT to protect the lung from destruction associated with the imbalance of proteases to antiproteases when AAT levels are low.